VIE/STMN (VIE/STMN)

Vienna Stock Exchange: VIE/STMN · EUR

€106

+0.00 (0.0%)· Recorded snapshot

Market cap	16.7B
Revenue (ttm)	2.9B
Net income (ttm)	399.9M
EPS (ttm)	€2.51
P/E (trailing)	42.3x
P/E (forward)	27.0x
Dividend	€1.09 (1.03%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2.9B
Net income (ttm): 399.9M
EPS (ttm): €2.51
P/E (trailing): 42.3x
P/E (forward): 27.0x
Market cap: 16.7B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E27

P25 n/aP50 n/aP75 n/a

Trailing P/E42.3

P25 n/aP50 n/aP75 n/a

ROE17

P25 n/aP50 n/aP75 n/a

ROIC21.6

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All VIE/STMN indicators

Market & fundamental data

Available fields

231

Groups with data

Currency

CHF

Showing 231 of 231 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Switzerland
Country code	AT
Earnings date	2026-10-28
Employees	11,582
Employees change	6
Employees growth	0.05%
Enterprise value	EUR 16.7B
Exchange	Vienna Stock Exchange
Financial currency	CHF
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1954
Industry	Medical Instruments & Supplies
Is primary listing	No
ISIN number	CH1175448666
Last earnings date	2026-10-28
Last refreshed	2026-10-30
Market cap	EUR 16.7B
Next earnings date	2027-02-17
Price	EUR 106.00
Price currency	EUR
Sector	Healthcare
SIC code	3843
Stock price date	2026-10-29
Symbol	vie/STMN
Website	https://www.straumann.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	59.94x
Average P/E ratio (3Y)	55.1x
Average P/E ratio (5Y)	54.33x
Earnings yield	2.37%
EV/Earnings	41.85x
EV/EBIT	24.25x
EV/EBITDA	20.19x
EV/FCF	40.51x
EV/Sales	5.86x
FCF / EV yield	2.47%
FCF yield	2.48%
Forward P/E	27.03x
Graham number	30.01842
Graham upside	-71.68%
Lynch fair value	EUR 12.72
Lynch upside	-88%
P/(FCF - SBC) ratio	42.64x
P/(OCF - SBC) ratio	30.61x
P/B ratio	6.73x
P/E ratio	42.25x
P/FCF ratio	40.34x
P/OCF ratio	29.41x
P/S ratio	5.84x
Price / tangible book value	10.97x
Price/EBITDA ratio	20.5x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.7%
EBITDA margin	28.47%
Effective tax rate	22.14%
FCF margin	14.43%
Gross margin	69.26%
Operating margin	24.7%
Pretax margin	18.05%
Profit margin	14%
Profit per employee	EUR 34,530
Profitable quarters	12
Profitable years	24
Revenue per employee	EUR 246,613
ROA	10.99%
ROA (5Y)	11.55%
ROCE	20.75%
ROE	17.05%
ROE (5Y)	24.08%
ROIC	21.62%
ROIC (5Y)	28.46%
SBC / revenue	0.78%
Tax / revenue	4%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-6.64%
EPS growth (Q)	5.84%
EPS growth (QoQ)	112.15%
EPS growth 10Y	6.1%
EPS growth 3Y	-0.56%
EPS growth 5Y	0.65%
EPS growth quarters	1
EPS growth years	0
FCF growth	8.78%
FCF growth (Q)	41.45%
FCF growth (QoQ)	-9.41%
FCF growth 3Y	10.22%
FCF growth 5Y	-5.63%
Gross profit growth	-0.75%
Gross profit growth (Q)	-0.02%
Gross profit growth 3Y	1.99%
Gross profit growth 5Y	6.04%
Net income growth	-6.39%
Net income growth (Q)	5.61%
Net income growth (QoQ)	109%
Net income growth 3Y	-0.53%
Net income growth 5Y	0.64%
Net income growth quarters	1
Net income growth years	0
OCF growth	4.62%
OCF growth (Q)	8.78%
OCF growth (QoQ)	-16.12%
OCF growth 10Y	10.54%
OCF growth 3Y	5.44%
OCF growth 5Y	-1.79%
Operating income growth	-0.69%
Operating income growth (Q)	-0.75%
Operating income growth 3Y	5.62%
Operating income growth 5Y	4.95%
Revenue growth	2.24%
Revenue growth (Q)	2.32%
Revenue growth (QoQ)	9.73%
Revenue growth 10Y	11.84%
Revenue growth 3Y	4.87%
Revenue growth 5Y	7.86%
Revenue growth quarters	12
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -153.6M
Depreciation and amortization	EUR 107.8M
EBIT	EUR 705.6M
EBITDA	EUR 813.1M
EPS	EUR 2.51
Financing cash flow	EUR -178.6M
Free cash flow	EUR 413.2M
Free cash flow minus SBC	EUR 390.9M
Gross profit	EUR 2B
Income taxes	EUR 114.2M
Investing cash flow	EUR -241.1M
Net borrowing	EUR 59.9M
Net cash flow	EUR 145.7M
Net income	EUR 399.9M
Operating cash flow minus SBC	EUR 544.5M
Operating income	EUR 705.6M
Revenue	EUR 2.9B
Stock-based compensation	EUR 22.3M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	8.15
Book value per share	EUR 15.54
Debt / EBITDA	0.61
Debt / equity	0.21
Debt / FCF	1.24
Interest coverage	20.72
Long-term assets	EUR 2.4B
Long-term liabilities	EUR 922.1M
Net cash (debt)	EUR -65M
Net cash / market cap	-0.39%
Net debt / EBITDA	0.08
Net debt / equity	0.03
Net debt / FCF	0.16
Piotroski F-Score	5
Property, plant and equipment	EUR 822.6M
Shareholders' equity	EUR 2.5B
Tangible book value	EUR 1.5B
Tangible book value per share	EUR 9.55
Total assets	EUR 4.2B
Total cash	EUR 449.1M
Total debt	EUR 514.2M
Total liabilities	EUR 1.7B

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.71
Current assets	EUR 1.9B
Current liabilities	EUR 824.5M
Current ratio	2.26
Inventory turnover	1.7
Net working capital	EUR 589.9M
Quick ratio	1.61
Working capital	EUR 1B
Working capital turnover	3.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	0.04%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-04-23
Dividend payment years	1
Dividend per share	EUR 1.09
Dividend yield	1.03%
Ex-dividend date	2026-04-21
Last dividend	EUR 1.09
Payout ratio	42.96%
Shareholder yield	1.07%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 102.41
1D price change	0%
1M price change	2.91%
1M total return	2.91%
1W price change	1.92%
1W total return	1.92%
1Y price change	11.7%
1Y return CAGR	12.96%
1Y total return	12.95%
20-day SMA	EUR 100.93
200-day SMA	EUR 101.63
3M price change	-2.75%
3M total return	-2.75%
50-day SMA	EUR 101.00
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 120.00
52-week high date	2026-07-01
52-week low	EUR 80.70
52-week low date	2026-03-23
6M price change	15.85%
6M total return	15.85%
All-time high	EUR 120.00
All-time high date	2026-07-01
All-time low	EUR 80.70
All-time low date	2026-03-23
Average true range (ATR)	EUR 1.77
Average volume	19.2
Change from 52-week high	-11.67%
Change from 52-week low	31.35%
Change from all-time high	-11.67%
Change from all-time low	31.35%
Change from open	0.95%
Day's gap	-0.94%
High price	EUR 106.00
Low price	EUR 105.00
Monthly RSI	0
Open price	EUR 105.00
Position in 52-week range	100%
Previous close	EUR 106.00
Price vs 150-day SMA	3.51%
Price vs 20-day SMA	5.03%
Price vs 200-day SMA	4.3%
Price vs 50-day SMA	4.95%
Relative volume	3.74
RSI	61.82
Sharpe ratio	0.19
Sortino ratio	0.49
Weekly RSI	54.23
YTD price change	6.15%
YTD total return	7.34%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	113.5M
Shares change (QoQ)	-0.07%
Shares change (YoY)	-0.04%
Shares held by insiders	28.81%
Shares held by institutions	27.6%

Deeper analysis on VIE/STMN

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/STMN report

Is a complete VIE/STMN research report available?

No complete published report is available for vie/STMN (VIE/STMN) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/STMN (VIE/STMN)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/STMN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/STMN indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/STMN

Frequently asked questions